TBX20 promotes doxorubicin resistance in breast cancer cells through enhanced ABCC1 expression and inhibition of mitophagy. - Nie, Shuai; Liu, Dejian; Hu, Jun; Gan, Yu; Mi, Liangliang (PLoS ONE, 2026)